Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03274622 · ClinicalTrials.gov registry record · NA

Efficacy of IMPACT in Infant Siblings of Children With ASD

A NA study of Autism Spectrum Disorder, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
97
Enrollment target
2
Study locations

NCT03274622 is a NA study of Autism Spectrum Disorder that has completed, run by Vanderbilt University. The registered enrollment target is 97 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (28% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03274622, a NA study of Autism Spectrum Disorder, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target
2
Study locations

Study Summary

Over a 5 year period infant and baby siblings of children with autism spectrum disorders (ASD) will be recruited to this study and will be randomized into 2 groups. Parents of the intervention group will receive 12 weeks of coaching in how to implement this intervention. Parents randomized to the control group will not receive intervention coaching. Both groups will attend a series of clinic appointments for data collection that occur at 3 month intervals over a 9 month period.

Conditions Studied

Interventions

  • BEHAVIORAL Impact Parent Training
  • BEHAVIORAL No Impact

Study Locations (2)

Tennessee

  • Vanderbilt University - Nashville

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2016-02-16
Est. Completion 2019-08-30
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT03274622

The ClinicalTrials.gov registry entry for NCT03274622 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (28% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Impact Parent Training is the first listed.

NCT03274622 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Washington.

Frequently Asked Questions

What is clinical trial NCT03274622 about?

NCT03274622 is a clinical study titled "Efficacy of IMPACT in Infant Siblings of Children With ASD". Over a 5 year period infant and baby siblings of children with autism spectrum disorders (ASD) will be recruited to this study and will be randomized into 2 groups. Parents of the intervention group will receive 12 weeks of coaching in how to implement this intervention. Parents randomized to the co...

What is the current status of trial NCT03274622?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2016-02-16. Estimated completion is 2019-08-30.

What conditions does trial NCT03274622 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT03274622?

The interventions under investigation include: Impact Parent Training (BEHAVIORAL), No Impact (BEHAVIORAL).

Who is sponsoring clinical trial NCT03274622?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03274622 being conducted?

This trial has 2 study locations across Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.